Search

everythinglearnresearchcommunity

for

Search:↓

Being allergic to linalool, a common fragrance ingredient, might contribute to developing frontal fibrosing alopecia.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Ritlecitinib is safe and may effectively treat alopecia areata.

Nanocrystals improve alopecia areata treatment by better targeting hair follicles.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

CLEC4D gene variants may increase the risk of alopecia areata in Jordanians.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

People with severe hair loss have lower zinc levels in their blood.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Improved diagnosis and affordable topical treatments are essential for managing alopecia areata in India.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

FFA patients have fewer melanocytes and thinner skin compared to others.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Alopecia areata patients have a higher risk of subclinical atherosclerosis, and carotid ultrasound can help assess their cardiovascular risk.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.